Jolanta Nowak

ORCID: 0000-0003-0462-0154
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pulmonary Hypertension Research and Treatments
  • Cardiovascular Function and Risk Factors
  • Nutrition and Health in Aging
  • Heart Failure Treatment and Management
  • Transplantation: Methods and Outcomes
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Erythropoietin and Anemia Treatment
  • Lipoproteins and Cardiovascular Health
  • Body Composition Measurement Techniques
  • Acute Myocardial Infarction Research
  • GDF15 and Related Biomarkers
  • Iron Metabolism and Disorders
  • Medical Imaging and Pathology Studies
  • Viral Infections and Immunology Research
  • Cardiac pacing and defibrillation studies
  • Atrial Fibrillation Management and Outcomes
  • Parathyroid Disorders and Treatments
  • Inflammatory Biomarkers in Disease Prognosis
  • Cardiac Fibrosis and Remodeling
  • Cardiac Valve Diseases and Treatments
  • Cardiac Arrhythmias and Treatments
  • Emergency and Acute Care Studies
  • Congenital Heart Disease Studies
  • Cardiovascular Effects of Exercise
  • Cardiovascular and exercise physiology

Silesian Center for Heart Disease
2015-2024

Medical University of Silesia
2015-2024

University of Opole
2020-2022

Górnośląskie Centrum Medyczne
1998-2019

University of Bielsko-Biała
2016

Institute of Cardiology
2010

Charles University
2004

Pedagogical University
2003

Beyond erythropoiesis, iron is involved in numerous biological processes crucial for maintenance of homeostasis. Patients with chronic heart failure (CHF) are prone to develop deficiency (ID), and supplementation improves their functional status quality life. We sought examine the relationship between ID survival patients systolic CHF. In a prospective observational study, we evaluated 546 stable CHF [age: 55 ± 11 (mean standard deviation) years, males: 88%, left ventricular ejection...

10.1093/eurheartj/ehq158 article EN European Heart Journal 2010-06-21

The prevalence of cardiac cachexia in chronic heart failure is approximately 5% to 15% and 18-month mortality rates can reach 50%. Treatment with angiotensin-converting enzyme inhibitors beta-blockers may confer some benefit but no proven therapy exists. We tested the effects an oral nutritional supplement cachectic patients failure. This was a prospective, randomized, double-blind, placebo-controlled pilot study which randomized 29 high-caloric (600 kcal) high-protein (20 g) or placebo for...

10.1007/s13539-010-0008-0 article EN cc-by-nc Journal of Cachexia Sarcopenia and Muscle 2010-09-01

Abnormalities in the oxidative and antioxidant states causing stress were both found heart failure (HF) of various aetiologies atherosclerosis. The goals study as follows: comparison parameters (OSP) ischaemic cardiomyopathy (ICM) (n = 479) nonischaemic (nICM) 295) patients; assessment relationships OSP with functional capacity (NYHA class), maximal oxygen consumption (max.O2), left ventricle ejection fraction (LVEF), NT-proBNP concentration; determination mutual relations subgroups patients...

10.1155/2019/7156038 article EN cc-by Oxidative Medicine and Cellular Longevity 2019-09-17

Albumin-to-globulin ratio (AGR) is emerged as a marker of impaired prognosis. We determined the predictive value AGR in patients with heart failure reduced ejection fraction (HFrEF).999 HFrEF were enrolled. Rates 1-year all-cause mortality compared between quartiles (Q). Moreover, multivariate survival analysis Cox's regression model and receiver operating characteristic analyses performed.90-day was highest Q1. an independent predictor 90-day mortality. Receiver revealed moderate diagnostic...

10.2217/bmm-2017-0378 article EN Biomarkers in Medicine 2018-06-05

Risk-factor identification and risk stratification are prerequisites to the effective primary secondary prevention of cardiovascular disease (CVD). Patients at highest benefit most from intensive risk-factor reduction. However, high-risk patients' group is heterogeneous, it increasingly recognised that there an 'extreme-risk' category patients who may require particularly close attention therapeutic approach. The aim this study was identify subgroups death following myocardial infarction...

10.1016/j.atherosclerosis.2021.08.024 article EN cc-by-nc-nd Atherosclerosis 2021-08-13

Abstract Introduction Pulmonary hypertension (PH) is common complication in advanced lung disease. Echocardiography provides additional information and may be useful to assess PH probability. Objectives The usefulness of combination well‐known echocardiographic parameters detecting patients with disease referred for transplantation was evaluated. Methods study population consisted 37 consecutive idiopathic pulmonary fibrosis (IPF), 20 chronic obstructive (COPD), 8 other interstitial...

10.1111/crj.12608 article EN The Clinical Respiratory Journal 2017-01-04

Out-of-hospital cardiac arrest (OHCA) is the sudden, unexpected loss of heart function, which occurs out specialist healthcare facilities and inevitably leads to death if uninterrupted by effective cardiopulmonary resuscitation (CPR).To evaluate circumstances basic epidemiological indices OHCA in population adult inhabitants Bielsko-Biala district within 12 months.On basis standard ambulance dispatch cards Emergency Medical Services (EMS) teams, a retrospective analysis was made 272 cases...

10.5603/kp.a2016.0086 article EN Kardiologia Polska 2016-05-25

Abstract Aims In recent years, survival in patients with breast cancer has increased. Despite the improvement outcomes of those patients, risk treatment‐related cardiotoxicity remains high, and its presence been associated a higher treatment termination thus lower therapeutic efficacy. Prior trials demonstrated that preventive initiation heart failure drugs, including renin–angiotensin–aldosterone inhibitors, might reduce cardiotoxicity. However, to date, no study investigated efficacy...

10.1002/ehf2.14466 article EN cc-by-nc ESC Heart Failure 2023-07-14

There is little published data on the association of platelet function and 25(OH)D concentration. We investigated associations between mean volume (MPV) concentration in patients with stable coronary artery disease. Study population was divided into three groups: group 1-25(OH)D < 10 ng/mL (N = 22), 2-25(OH)D 10-20 42), 3-25(OH)D > 20 14). groups shared similar demographics. MPV values were highest 1, moderate 2, lowest 3 (11.1 vs 10.4 9.8 fL P 0.001). a negative correlation (R - 0.38, ROC...

10.1007/s00380-018-1182-9 article EN cc-by Heart and Vessels 2018-05-03

Background: The benefits of oral anticoagulation (OAC) therapy are undeniable. However, such treatment is contraindicated in 2%–10% patients. According to the latest guidelines, percutaneous left atrial appendage occlusion (LAAO) may be considered stroke prevention. Aims: We analyzed data patients from Polish population, who had undergone LAAO procedures Silesian Province based on limited reports. Methods: SILCARD database all underwent between 2006 and 2019, databases centers performing...

10.33963/kp.a2022.0047 article EN Kardiologia Polska 2022-03-31

WHAT'S NEW?We compared baseline characteristics, hospital readmission, and mortality rates in individuals with heart failure (HF) reduced (HFrEF), mildly (HFmrEF), preserved (HFpEF) ejection fraction diagnosed according to the universal definition classification of HF.According our knowledge, this is first publication that used HF classify groups.Moreover, screening was performed all patients hospitalized cardiac department, regardless previous diagnosis.Our study showed all-cause higher...

10.33963/v.phj.99549 article EN Kardiologia Polska 2024-03-20

The aim of the study was to evaluate occurence death and major adverse cardiac events (MACE) in patients with normal (group A) elevated B) plasma bilirubin levels.We evaluated 124 (83% males, mean age 50.1 +/- 7.7 yrs) New York Heart Association class II III hypertension-related chronic heart failure. We assessed MACE (death, urgent transplantation readmission hospital).Groups A B comprised 77 47 respectively. independent predictors group were: N-terminal pro-brain natriuretic peptide...

10.20452/pamw.138 article EN Polskie Archiwum Medycyny Wewnętrznej 2007-05-01

kidney. 2 All of these cells are important for cardiovascular function.Heart failure (HF) is a complex clinical syndrome increasing importance, 3 in which the hyperadrenergic state, inflammation, and various metabolic derangements lead to accelerated INTRODUCTION There an recognition role extracellular calcium signaling organ functioning survival. 1The activation calcium-sensing receptors implicated regulation myocytes as well endothelial, epithelial, juxtaglomerular

10.20452/pamw.2646 article EN Polskie Archiwum Medycyny Wewnętrznej 2015-01-12

The above article was originally published with standard subscription-based access, however, the authors have since decided to take up Oxford Open model of publication. is now freely available online …

10.1093/eurheartj/ehr115 article EN European Heart Journal 2011-04-01
Coming Soon ...